Cargando…
In vivo evolution of biopsy‐proven inflammatory demyelination quantified by R2t* mapping
A 35‐year‐old man with an enhancing tumefactive brain lesion underwent biopsy, revealing inflammatory demyelination. We used quantitative Gradient‐Recalled‐Echo (qGRE) MRI to visualize and measure tissue damage in the lesion. Two weeks after biopsy, qGRE showed significant R2t* reduction in the left...
Autores principales: | Xiang, Biao, Wen, Jie, Lu, Hsiang‐Chih, Schmidt, Robert E., Yablonskiy, Dmitriy A., Cross, Anne H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317639/ https://www.ncbi.nlm.nih.gov/pubmed/32367692 http://dx.doi.org/10.1002/acn3.51052 |
Ejemplares similares
-
Autopsy-proven demyelination associated with infliximab treatment
por: Bradshaw, Michael J., et al.
Publicado: (2016) -
Predictors of long-term outcome in patients with biopsy proven inflammatory cardiomyopathy
por: Marc-Alexander, Ohlow, et al.
Publicado: (2018) -
Clinicopathological features of inflammatory demyelinating diseases in biopsy
por: Wei, Jia, et al.
Publicado: (2020) -
Stronger Microstructural Damage Revealed in Multiple Sclerosis Lesions With Central Vein Sign by Quantitative Gradient Echo MRI
por: Levasseur, Victoria A., et al.
Publicado: (2022) -
Clinicopathological characteristics and risk factors in elderly patients with biopsy-proven IgA nephropathy
por: Tan, Jiaxing, et al.
Publicado: (2022)